-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Oppenheimer Initiates Coverage on Voyager Therapeutics With Outperform Rating, $14 Price Target

Oppenheimer Initiates Coverage on Voyager Therapeutics With Outperform Rating, $14 Price Target

MT Newswires · 03/10/2023 03:23